{
    "version": "2.1.0",
    "guideline_source": "Based on PRECISE-HBR bleeding risk assessment for PCI patients",
    "scoring_logic": {
        "scoring_method": "PRECISE-HBR",
        "description": "7-item PRECISE-HBR score for bleeding risk prediction in PCI patients",
        "score_range": "0-50+ points",
        "high_risk_threshold": 23,
        "very_high_risk_threshold": 27,
        "interpretation": "≤22 = non-high risk (<4%), 23-26 = high risk (4-6%), ≥27 = very high risk (≥6%)"
    },
    "precise_hbr_parameters": {
        "age": {
            "description": "Patient age in years",
            "calculation_type": "direct_value",
            "min_value": 20,
            "max_value": 100,
            "score_contribution": "Age-based scoring (exact values need supplemental data)"
        },
        "hemoglobin": {
            "description": "Hemoglobin level in g/dL",
            "calculation_type": "inverse_value",
            "min_value": 8.0,
            "max_value": 18.0,
            "score_contribution": "Lower Hb = higher bleeding risk"
        },
        "egfr": {
            "description": "Estimated glomerular filtration rate in mL/min/1.73m²",
            "calculation_type": "inverse_value",
            "min_value": 15,
            "max_value": 150,
            "score_contribution": "Lower eGFR = higher bleeding risk"
        },
        "white_blood_cell_count": {
            "description": "White blood cell count in ×10⁹/L",
            "calculation_type": "direct_value",
            "min_value": 2.0,
            "max_value": 25.0,
            "enabled": true,
            "score_contribution": "Higher WBC = higher bleeding risk"
        },
        "previous_bleeding": {
            "description": "History of spontaneous bleeding",
            "calculation_type": "binary",
            "score_contribution": "Yes = significant points added"
        },
        "oral_anticoagulation": {
            "description": "Long-term oral anticoagulation therapy",
            "calculation_type": "binary",
            "score_contribution": "Warfarin, DOACs, etc. increase bleeding risk"
        },
        "arc_hbr_factors": {
            "description": "ARC-HBR bleeding risk factors",
            "calculation_type": "binary",
            "factors": [
                "thrombocytopenia",
                "chronic_bleeding_diathesis", 
                "active_malignancy",
                "liver_cirrhosis_portal_hypertension",
                "nsaids_corticosteroids"
            ],
            "score_contribution": "Presence of ≥1 factor increases risk"
        }
    },
    "precise_hbr_snomed_codes": {
        "bleeding_diathesis": {
            "parent_code": "64779008",
            "specific_codes": [
                "64779008",
                "234717003",
                "77517001",
                "50048000"
            ],
            "description": "Chronic bleeding diathesis (慢性出血性體質)"
        },
        "prior_bleeding": {
            "parent_codes": [
                "74474003",
                "50960005",
                "1386000",
                "236002003",
                "443826006",
                "233703007",
                "59282003",
                "3298000",
                "9957009",
                "17338001"
            ],
            "specific_codes": [
                "74474003",
                "50960005",
                "1386000",
                "236002003",
                "443826006",
                "233703007",
                "59282003",
                "3298000",
                "9957009",
                "17338001",
                "162050001",
                "131148009",
                "428860009",
                "429044007",
                "443760008",
                "275190004",
                "95545007"
            ],
            "description": "Prior bleeding events (既往出血史)"
        },
        "active_cancer": {
            "parent_code": "363346000",
            "exclude_codes": [
                "254637007",
                "254632001"
            ],
            "description": "Active malignant neoplastic disease, excluding specific skin cancers"
        },
        "liver_cirrhosis": {
            "parent_code": "19943007",
            "description": "Liver cirrhosis with portal hypertension"
        },
        "thrombocytopenia": {
            "parent_code": "415116008",
            "specific_codes": [
                "415116008",
                "302872006",
                "234381000"
            ],
            "threshold": {
                "value": 100,
                "unit": "10^9/L",
                "description": "Platelet count < 100 ×10⁹/L"
            },
            "description": "Thrombocytopenia (血小板減少症)"
        }
    },
    "bleeding_history_keywords": [
        "with bleeding",
        "with hemorrhage", 
        "gastrointestinal bleeding",
        "GI bleeding",
        "upper GI bleed",
        "lower GI bleed",
        "peptic ulcer bleeding",
        "intracranial hemorrhage",
        "brain hemorrhage",
        "subarachnoid hemorrhage",
        "subdural hemorrhage",
        "epidural hemorrhage",
        "spontaneous bleeding",
        "major bleeding",
        "hematemesis",
        "melena",
        "hematochezia"
    ],
    "laboratory_value_extraction": {
        "hemoglobin_loinc_codes": [
            "718-7"
        ],
        "hemoglobin_text_search": [
            "Hemoglobin",
            "Hgb",
            "Hb"
        ],
        "creatinine_loinc_codes": [
            "2160-0"
        ],
        "creatinine_text_search": [
            "Creatinine",
            "Creat"
        ],
        "egfr_loinc_codes": [
            "33914-3"
        ],
        "egfr_text_search": [
            "Estimated GFR",
            "eGFR",
            "Glomerular filtration rate"
        ],
        "white_blood_cell_loinc_codes": [
            "6690-2"
        ],
        "wbc_text_search": [
            "WBC",
            "White blood cell"
        ],
        "platelet_loinc_codes": [
            "26515-7"
        ],
        "platelet_text_search": [
            "Platelets",
            "Platelet count",
            "PLT"
        ],
        "unit_conversions": {
            "hemoglobin": {
                "g/L_to_g/dL": 0.1,
                "mmol/L_to_g/dL": 1.61
            }
        }
    },
    "risk_interpretation": {
        "non_high_risk": {
            "score_range": [0, 22],
            "label": "Not high bleeding risk",
            "recommendation": "1-year risk of major bleeding: 0.89%",
            "color": "green",
            "bleeding_risk_percent": "0.89%"
        },
        "high_risk": {
            "score_range": [23, 26],
            "label": "HBR (score 23-26)", 
            "recommendation": "1-year risk of major bleeding: 4%",
            "color": "orange",
            "bleeding_risk_percent": "4%"
        },
        "very_high_risk": {
            "score_range": [27, 100],
            "label": "Very HBR (score ≥27)",
            "recommendation": "1-year risk of major bleeding: 6%",
            "color": "red",
            "bleeding_risk_percent": "6%"
        }
    },
    "clinical_decision_support": {
        "high_risk_threshold": 23,
        "very_high_risk_threshold": 27,
        "dapt_recommendations": {
            "high_risk": {
                "duration": "3-6 months",
                "monitoring": "Enhanced bleeding surveillance",
                "considerations": [
                    "Consider P2Y12 inhibitor de-escalation",
                    "Evaluate need for PPI",
                    "Consider alternative antiplatelet strategies"
                ]
            },
            "low_to_moderate_risk": {
                "duration": "12 months",
                "monitoring": "Standard monitoring",
                "considerations": [
                    "Standard dual antiplatelet therapy",
                    "Regular assessment of bleeding risk factors"
                ]
            }
        }
    },
    "validation_info": {
        "original_study": "Costa F, et al. Lancet 2017",
        "validation_studies": [
            "Choi SY, et al. Circ Cardiovasc Interv 2018",
            "Dannenberg L, et al. Int J Cardiol Heart Vasc 2021"
        ],
        "c_statistic": "0.67-0.72",
        "population": "Post-PCI patients on DAPT"
    },
    "tradeoff_analysis": {
        "model_file": "fhir_resources/valuesets/arc-hbr-model.json",
        "baseline_event_rates": {
            "bleeding_rate_percent": 2.5,
            "thrombotic_rate_percent": 2.5,
            "description": "Baseline 1-year event rates for reference group (ARC-HBR cohort, Galli M, et al. JAMA Cardiology 2021)"
        },
        "risk_factor_thresholds": {
            "age_threshold": 65,
            "hemoglobin_ranges": {
                "moderate": {
                    "min": 11,
                    "max": 13,
                    "description": "Hemoglobin 11-12.9 g/dL"
                },
                "severe": {
                    "max": 11,
                    "description": "Hemoglobin < 11 g/dL"
                }
            },
            "egfr_ranges": {
                "moderate": {
                    "min": 30,
                    "max": 60,
                    "description": "eGFR 30-59 mL/min"
                },
                "severe": {
                    "max": 30,
                    "description": "eGFR < 30 mL/min"
                }
            }
        },
        "snomed_codes": {
            "copd": "13645005",
            "nstemi": "164868009",
            "stemi": "164869001",
            "diabetes": "73211009",
            "myocardial_infarction": "22298006",
            "complex_pci": "397682003",
            "bare_metal_stent": "427183000"
        },
        "rxnorm_codes": {
            "warfarin": "11289",
            "rivaroxaban": "21821",
            "apixaban": "1364430",
            "dabigatran": "1037042",
            "edoxaban": "1537033"
        }
    }
} 